{"brief_title": "Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)", "brief_summary": "The purpose of this study is to assess the biological activity of ZD6126 in subjects with newly diagnosed metastatic renal cell carcinoma (stage IV).", "condition": "Kidney Neoplasms", "intervention_type": "Drug", "intervention_name": "Placebo", "criteria": "Inclusion Criteria: - Newly diagnosed metastatic renal cell carcinoma - Suitable for nephrectomy Exclusion Criteria: - Prior chemotherapy, biological therapy or radiation therapy for renal cell carcinoma or within the last 3 years for any other cancer - Significant cardiac event within 3 months of entry - Any history of coronary angioplasty or history of myocardial infarction", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00065572.xml"}